CGRP inhibitorReviewed for 2026 plan year

Does Blue Cross Blue Shield Cover Emgality?

The verdict

Covered on most plans

BCBS plans broadly cover Emgality for migraine prevention, but prior authorization and step therapy are required — you must typically document failure of 2 or more oral migraine preventives (such as topiramate or propranolol) and 4 or more migraine days per month. Because BCBS is 30-plus independent licensees, tier placement and PA specifics vary by state plan. About 60% of Medicare enrollees have brand Emgality access. Verify on your state BCBS formulary.

MedicareConditional
CommercialCovered
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Blue Cross Blue Shield drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice
  • Medicare covers Emgality for only about 60% of enrollees — the lowest access rate among payer channels — with most requiring prior authorization.

    GoodRx/MMIT formulary access data, February 2025

  • BCBS is 30-plus independent licensees; tier placement, PBM, and step-therapy sequence for Emgality vary by state plan — there is no single national BCBS policy.

    BCBS Association / state licensee formularies

  • The Emgality Savings Card can reduce commercial cost to as little as $35/month; it is not available for Medicare or Medicaid members.

    Eli Lilly Emgality savings program

Medicare vs. commercial coverage

Whether Blue Cross Blue Shield covers Emgality depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Conditional

Medicare Part D (BCBS MA-PD plans): approximately 60% of Medicare enrollees have access to brand Emgality, with most requiring PA per GoodRx/MMIT data (February 2025). Medicare offers less Emgality access than commercial or Medicaid channels. Coinsurance is typically 25–33% after the deductible. The 2026 Part D out-of-pocket cap of $2,100 limits annual exposure. The Emgality Savings Card is not available to Medicare beneficiaries. Step-therapy and formulary specifics vary by BCBS MA-PD plan — verify on your plan drug list.

Commercial / Employer

Group & marketplace plans

Covered

Commercial/Employer: Emgality is covered on the specialty or Tier 3 with PA and step therapy. The real gate is step therapy: most BCBS plans require documented failure of at least 2 oral preventives (topiramate, propranolol, amitriptyline or similar) and documentation of 4 or more migraine days per month before Emgality is approved. Tier and PBM vary across 30-plus BCBS licensees — verify on your state BCBS formulary. The Emgality Savings Card can reduce commercial cost to as little as $35 or $0. ACA/Individual: specialty or Tier 3 with PA where offered. Medicaid (BCBS-managed): covered per state PDL with PA; broader access but 60-plus percent require PA and step therapy; nominal cost-share.

The 5 boxes you must tick to get approved

Commercial plans that will consider Emgality require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 5

0 of 5 requirements selected. Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

Your cost, three ways

What Emgality actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

Cash price approximately $650–$800/month (list/WAC estimate); SingleCare reports approximately $981 for a single 120 mg pen. Treat as an estimate — verify with pharmacy.

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Commercial: specialty or Tier 3 coinsurance varies by BCBS licensee; the Emgality Savings Card can reduce cost to as little as $35 (some sources $0) for eligible commercially insured patients. Medicare Part D: typically 25–33% coinsurance after the deductible, capped at $2,100 for the year (2026 cap). Medicaid: nominal cost-share per state plan.

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

Emgality Savings Card: as little as $35/month (some sources report $0) for eligible commercially insured patients. Not available to Medicare or Medicaid beneficiaries. Contact Eli Lilly or visit emgality.com to enroll.

Reduced copay through the assistance program, where eligible.

All figures are estimates. Coinsurance varies by BCBS licensee and specific plan tier. Confirm your cost-share with your state BCBS plan before filling.

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Find your specific state BCBS formulary

    There is no single national BCBS Emgality policy — each of the 30-plus BCBS licensees has its own formulary and PA criteria. Go to your state BCBS plan's website (e.g., bcbsil.com, bcbsnc.com, blueshieldca.com) and use the drug or formulary lookup tool to search for 'galcanezumab' or 'Emgality' on your specific plan.

  2. 2

    Confirm step-therapy requirements with your neurologist

    Before applying for PA, verify with your treating neurologist or headache specialist which oral preventives you have already tried and failed. You will need documentation of at least 2 prior oral preventives (and failure due to inefficacy or side effects) and your migraine frequency to satisfy step-therapy requirements.

  3. 3

    Have your specialist submit the prior authorization

    Ask your neurologist or headache specialist to initiate the PA request through your state BCBS plan. The submission should include diagnosis, migraine frequency, prior-treatment history, and clinical rationale. Ask about the specific specialty pharmacy your plan requires for Emgality dispensing.

Options if Blue Cross Blue Shield won't cover Emgality

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Aimovig (erenumab)

Another CGRP inhibitor for migraine prevention. May carry a different formulary tier on your BCBS plan — check your state BCBS formulary to compare placement and step-therapy requirements.

Ajovy (fremanezumab)

A third CGRP inhibitor for migraine prevention. May be preferred on some BCBS licensee formularies. Check your state plan's drug list for tier and PA requirements.

Oral preventive therapies

Topiramate, propranolol, amitriptyline, and valproate are typically Tier 1 or 2 generics on BCBS plans and covered with minimal PA.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.